Osteocyte-derived erythroferrone regulates liver hepcidin during stress erythropoiesis
Our knowledge of which bone marrow cells affect red cell production is still incomplete. To explore the role of osteocytes in the process we performed bulk RNAseq of osteocytes isolated from control and phlebotomized mice. The second top-upregulated gene following phlebotomy was Erfe - erythroferrone. Erfe expression in osteocytes was also upregulated after erythropoietin (EPO) treatment and hypoxia in vitro. To explore if osteocytes contribute to systemic ERFE levels, we generated two mouse models. We first transplanted wild-type bone marrow (BM) in Erfe-/- mice creating a model where ERFE is produced in the BM but not by osteocytes. After phlebotomy, liver hepcidin suppression was significantly lower in mice where the osteocytes could not produce ERFE. To confirm that osteocytes are responsible for this difference, we generated mice lacking EPO receptors in osteocytes by crossing Eporflox/flox and Dmp1-Cre mice. After phlebotomy, these mice showed reduced hepcidin suppression in the liver and higher circulating serum hepcidin levels compared with controls. Our work identified a novel function of osteocytes in suppressing systemic hepcidin levels during stress erythropoiesis.
Authors
- Ildikó Szalayova (ORCID: https://orcid.org/0000-0002-6857-2297)
- Lynn Vitale‐Cross (ORCID: https://orcid.org/0000-0001-7850-547X)
- Abhinav Parashar
- Luis Fernandez de Castro
- Eva Mezey
- Vamsee Dhar Myneni
Institutions
- National Institutes of Health (US)
- National Institute of Dental and Craniofacial Research (US)
Publication Details
- Journal
- Blood Advances
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1182/bloodadvances.2025017231
- Primary Topic
- Iron Metabolism and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Institute of Dental and Craniofacial Research